188 related articles for article (PubMed ID: 28941201)
1. Synthesis and in vitro Biological Evaluation of Ferrocenyl Side-Chain-Functionalized Paclitaxel Derivatives.
Plażuk D; Wieczorek A; Ciszewski WM; Kowalczyk K; Błauż A; Pawlędzio S; Makal A; Eurtivong C; Arabshahi HJ; Reynisson J; Hartinger CG; Rychlik B
ChemMedChem; 2017 Nov; 12(22):1882-1892. PubMed ID: 28941201
[TBL] [Abstract][Full Text] [Related]
2. Ferrocenyl Paclitaxel and Docetaxel Derivatives: Impact of an Organometallic Moiety on the Mode of Action of Taxanes.
Wieczorek A; Błauż A; Żal A; Arabshahi HJ; Reynisson J; Hartinger CG; Rychlik B; Plażuk D
Chemistry; 2016 Aug; 22(32):11413-21. PubMed ID: 27376707
[TBL] [Abstract][Full Text] [Related]
3. 2,4-Disubstituted Quinazoline Derivatives Act as Inducers of Tubulin Polymerization: Synthesis and Cytotoxicity.
Moghadam ES; Tehrani MH; Csuk R; Fischer L; Faramarzi MA; Rashidi A; Javadi I; Amini M
Anticancer Agents Med Chem; 2019; 19(8):1048-1057. PubMed ID: 30868963
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, cytotoxic evaluation and molecular docking study of 2-alkylthio-4-(2,3,4-trimethoxyphenyl)-5-aryl-thiazoles as tubulin polymerization inhibitors.
Salehi M; Amini M; Ostad SN; Riazi GH; Assadieskandar A; Shafiei B; Shafiee A
Bioorg Med Chem; 2013 Dec; 21(24):7648-54. PubMed ID: 24238904
[TBL] [Abstract][Full Text] [Related]
5. Preclinical pharmacologic evaluation of MST-997, an orally active taxane with superior in vitro and in vivo efficacy in paclitaxel- and docetaxel-resistant tumor models.
Sampath D; Greenberger LM; Beyer C; Hari M; Liu H; Baxter M; Yang S; Rios C; Discafani C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3459-69. PubMed ID: 16740771
[TBL] [Abstract][Full Text] [Related]
6. Substituents at the C3' and C3'N positions are critical for taxanes to overcome acquired resistance of cancer cells to paclitaxel.
Jelínek M; Balušíková K; Daniel P; Němcová-Fürstová V; Kirubakaran P; Jaček M; Wei L; Wang X; Vondrášek J; Ojima I; Kovář J
Toxicol Appl Pharmacol; 2018 May; 347():79-91. PubMed ID: 29625142
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
[TBL] [Abstract][Full Text] [Related]
8. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.
Cai P; Lu P; Sharom FJ; Fang WS
Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
[TBL] [Abstract][Full Text] [Related]
10. β-Diketonate versus β-Ketoiminate: The Importance of a Ferrocenyl Moiety in Improving the Anticancer Potency.
Allison M; Wilson D; Pask CM; McGowan PC; Lord RM
Chembiochem; 2020 Jul; 21(14):1988-1996. PubMed ID: 32176811
[TBL] [Abstract][Full Text] [Related]
11. Biological Evaluation of Ferrocenyl Olefins: Cancer Cell Growth Inhibition, ROS Production, and Apoptosis Activity.
Sun A; Lin J; Pi C; Xu R; Cui X
Arch Pharm (Weinheim); 2016 Mar; 349(3):186-92. PubMed ID: 26841261
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of 2-phenylquinoline-4-carboxamide derivatives as a new class of tubulin polymerization inhibitors.
Zhu L; Luo K; Li K; Jin Y; Lin J
Bioorg Med Chem; 2017 Nov; 25(21):5939-5951. PubMed ID: 28988750
[TBL] [Abstract][Full Text] [Related]
13. A fluorine scan of a tubulin polymerization inhibitor isocombretastatin A-4: Design, synthesis, molecular modelling, and biological evaluation.
Naret T; Bignon J; Bernadat G; Benchekroun M; Levaique H; Lenoir C; Dubois J; Pruvost A; Saller F; Borgel D; Manoury B; Leblais V; Darrigrand R; Apcher S; Brion JD; Schmitt E; Leroux FR; Alami M; Hamze A
Eur J Med Chem; 2018 Jan; 143():473-490. PubMed ID: 29202409
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors.
Ramya PVS; Guntuku L; Angapelly S; Digwal CS; Lakshmi UJ; Sigalapalli DK; Babu BN; Naidu VGM; Kamal A
Eur J Med Chem; 2018 Jan; 143():216-231. PubMed ID: 29174816
[TBL] [Abstract][Full Text] [Related]
15. Hybrid Pharmacophore Design, Molecular Docking, Synthesis, and Biological Evaluation of Novel Aldimine-Type Schiff Base Derivatives as Tubulin Polymerization Inhibitor.
Ameri A; Khodarahmi G; Forootanfar H; Hassanzadeh F; Hakimelahi GH
Chem Biodivers; 2018 Mar; 15(3):e1700518. PubMed ID: 29292595
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
Cao D; Liu Y; Yan W; Wang C; Bai P; Wang T; Tang M; Wang X; Yang Z; Ma B; Ma L; Lei L; Wang F; Xu B; Zhou Y; Yang T; Chen L
J Med Chem; 2016 Jun; 59(12):5721-39. PubMed ID: 27213819
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of 4-anilinoquinoline derivatives as novel potent tubulin depolymerization agents.
Zhou Y; Yan W; Cao D; Shao M; Li D; Wang F; Yang Z; Chen Y; He L; Wang T; Shen M; Chen L
Eur J Med Chem; 2017 Sep; 138():1114-1125. PubMed ID: 28763646
[TBL] [Abstract][Full Text] [Related]
18. Novel ferrocenylbisphosphonate hybrid compounds: Synthesis, characterization and potent activity against cancer cell lines.
Anusionwu CG; Aderibigbe BA; Adeyemi SA; Ubanako P; Oselusi SO; Choonara YE; Yangkou Mbianda X
Bioorg Med Chem; 2022 Mar; 58():116652. PubMed ID: 35180594
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of 4-morpholino-6-(1,2,3,6-tetrahydropyridin-4-yl)-N-(3,4,5-trimethoxyphenyl)-1,3,5-triazin-2-amine analogues as tubulin polymerization inhibitors.
Narva S; Chitti S; Amaroju S; Bhattacharjee D; Rao BB; Jain N; Alvala M; Sekhar KVGC
Bioorg Med Chem Lett; 2017 Aug; 27(16):3794-3801. PubMed ID: 28684120
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of pyrazole/isoxazole linked arylcinnamides as tubulin polymerization inhibitors and potential antiproliferative agents.
Kamal A; Shaik AB; Rao BB; Khan I; Bharath Kumar G; Jain N
Org Biomol Chem; 2015 Oct; 13(40):10162-78. PubMed ID: 26303171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
